Exhaled breath condensate eicosanoid levels associate with asthma and its severity

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 3, 2013, Pages 547-553

  Kazani, Shamsah ^a   Planaguma, Anna ^a   Ono, Emiko ^a   Bonini, Matteo ^a   Zahid, Muhammad ^a   Marigowda, Gautham ^a   Wechsler, Michael E ^a   Levy, Bruce D ^a   Israel, Elliot ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Asthma; biomarkers; breath tests; eicosanoids; leukotriene B4; lipoxin A4

Indexed keywords

ICOSANOID; LEUKOTRIENE B4; LIPOXIN A;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BREATHING; CONTROLLED STUDY; DISEASE SEVERITY; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ASTHMA; BAL; BIOMARKERS; BREATH TESTS; BRONCHOALVEOLAR LAVAGE; CYSLT; CYSTEINYL LEUKOTRIENE; EBC; EICOSANOIDS; EXHALED BREATH CONDENSATE; FENO; FRACTION OF EXHALED NITRIC OXIDE; ICS; INHALED CORTICOSTEROID; LEUKOTRIENE B(4); LIPOXIN A(4); LTB(4); LXA(4);

ADOLESCENT; ADULT; ASTHMA; BREATH TESTS; EXHALATION; FEMALE; HUMANS; LEUKOTRIENE B4; LIPOXINS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84883225321     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.01.058     Document Type: Article

References (39)

1. J.M. Drazen, E. Israel, and P.M. O'Byrne Treatment of asthma with drugs modifying the leukotriene pathway N Engl J Med 340 1999 197 206
2. L. Borish The role of leukotrienes in upper and lower airway inflammation and the implications for treatment Ann Allergy Asthma Immunol 88 2002 16 22
3. C.N. Serhan, and B. Levy Novel pathways and endogenous mediators in anti-inflammation and resolution Chem Immunol Allergy 83 2003 115 145
4. B.D. Levy, G.T. De Sanctis, P.R. Devchand, E. Kim, K. Ackerman, and B.A. Schmidt Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4) Nat Med 8 2002 1018 1023
5. C. Bandeira-Melo, B.L. Diaz, R.S. Cordeiro, P.J. Jose, C.N. Serhan, and M.A. Martins Inhibition of allergen-induced eosinophil migration by lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 Adv Exp Med Biol 507 2002 211 216
6. K. Gronert, T. Martinsson-Niskanen, S. Ravasi, N. Chiang, and C.N. Serhan Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses Am J Pathol 158 2001 3 9
7. K.F. Badr, D.K. DeBoer, M. Schwartzberg, and C.N. Serhan Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor Proc Natl Acad Sci U S A 86 1989 3438 3442
8. P.E. Christie, B.W. Spur, and T.H. Lee The effects of lipoxin A4 on airway responses in asthmatic subjects Am Rev Respir Dis 145 1992 1281 1284
9. T.H. Lee, C.E. Horton, U. Kyan-Aung, D. Haskard, A.E. Crea, and B.W. Spur Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine Clin Sci (Lond) 77 1989 195 203
10. B.D. Levy, C. Bonnans, E.S. Silverman, L.J. Palmer, G. Marigowda, and E. Israel Diminished lipoxin biosynthesis in severe asthma Am J Respir Crit Care Med 172 2005 824 830
11. A. Planaguma, S. Kazani, G. Marigowda, O. Haworth, T.J. Mariani, and E. Israel Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma Am J Respir Crit Care Med 178 2008 574 582
12. C. Bonnans, I. Vachier, C. Chavis, P. Godard, J. Bousquet, and P. Chanez Lipoxins are potential endogenous antiinflammatory mediators in asthma Am J Respir Crit Care Med 165 2002 1531 1535
13. M. Sanak, B.D. Levy, C.B. Clish, N. Chiang, K. Gronert, and L. Mastalerz Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics Eur Respir J 16 2000 44 49
14. S.H. Wu, P.L. Yin, Y.M. Zhang, and H.X. Tao Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree Pediatr Pulmonol 45 2010 333 340
15. G.E. Celik, F.O. Erkekol, Z. Misirligil, and M. Melli Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity Clin Exp Allergy 37 2007 1494 1501
16. I. Vachier, C. Bonnans, C. Chavis, M. Farce, P. Godard, and J. Bousquet Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound J Allergy Clin Immunol 115 2005 55 60
17. D. Gras, A. Bourdin, I. Vachier, L. de Senneville, C. Bonnans, and P. Chanez An ex vivo model of severe asthma using reconstituted human bronchial epithelium J Allergy Clin Immunol 129 2012 1259 1266.e1
18. I. Horváth, J. Hunt, P.J. Barnes, K. Alving, A. Antczak, and E. Baraldi Exhaled breath condensate: methodological recommendations and unresolved questions Eur Respir J 26 2005 523 548
19. S. Kazani, and E. Israel Exhaled breath condensates in asthma: diagnostic and therapeutic implications J Breath Res 4 2010 047001
20. L.G. Fritscher, M. Post, M.T. Rodrigues, F. Silverman, M. Balter, and K.R. Chapman Profile of eicosanoids in breath condensate in asthma and COPD J Breath Res 6 2012 026001
21. R.A. Hasan, E. O'Brien, and P. Mancuso Lipoxin A4 and 8-isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus Pediatr Crit Care Med 3 2012 141 145
22. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society Am J Respir Crit Care Med 162 2000 2341 2351
23. National Institutes of Health Expert panel report 3 (EPR3): guidelines for the diagnosis and management of asthma. NHLBI/WHO workshop report 2010 National Institutes of Health National Heart Lung and Blood Institute Bethesda Publication no. 08-4051
24. W.C. Moore, E.R. Bleecker, D. Curran-Everett, S.C. Erzurum, B.T. Ameredes, and L. Bacharier Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program J Allergy Clin Immunol 119 2007 405 413
25. S.J. Szefler, S. Wenzel, R. Brown, S.C. Erzurum, J.V. Fahy, and R.G. Hamilton Asthma outcomes: biomarkers J Allergy Clin Immunol 129 suppl 2012 S9 S23
26. C.N. Serhan Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution Prostaglandins Other Lipid Mediat 68-69 2002 433 455
27. Y. Ogawa, and W.J. Calhoun The role of leukotrienes in airway inflammation J Allergy Clin Immunol 118 2006 789 798
28. H.E. Claesson, B. Odlander, and P.J. Jakobsson Leukotriene B4 in the immune system Int J Immunopharmacol 14 1992 441 449
29. K. Kostikas, M. Gaga, G. Papatheodorou, T. Karamanis, D. Orphanidou, and S. Loukides Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma Chest 127 2005 1553 1559
30. B.D. Levy, P. Kohli, K. Gotlinger, O. Haworth, S. Hong, and S. Kazani Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness J Immunol 178 2007 496 502
31. P.K. Bhavsar, B.D. Levy, M.J. Hew, M.A. Pfeffer, S. Kazani, and E. Israel Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma Respir Res 11 2010 71
32. C. Mondino, G. Ciabattoni, P. Koch, R. Pistelli, A. Trové, and P.J. Barnes Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children J Allergy Clin Immunol 114 2004 761 767
33. Z. Csoma, S.A. Kharitonov, B. Balint, A. Bush, N.M. Wilson, and P.J. Barnes Increased leukotrienes in exhaled breath condensate in childhood asthma Am J Respir Crit Care Med 166 2002 1345 1349
34. K.W. McGrath, N. Icitovic, H.A. Boushey, S.C. Lazarus, E.R. Sutherland, and V.M. Chinchilli A Large Subgroup of Mild-to-Moderate Asthma is Persistently Non-Eosinophilic Am J Respir Crit Care Med 185 2012 612 619
35. P.E. Silkoff, P. McClean, M. Spino, L. Erlich, A.S. Slutsky, and N. Zamel Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients Chest 119 2001 1322 1328
36. 4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease Proc Natl Acad Sci U S A 109 2012 935 940
37. O. Kowal-Bielecka, K. Kowal, O. Distler, J. Rojewska, A. Bodzenta-Lukaszyk, and B.A. Michel Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators Arthritis Rheum 52 2005 3783 3791
38. J. Yang, J.P. Eiserich, C.E. Cross, B.M. Morrissey, and B.D. Hammock Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients Free Radic Biol Med 53 2012 160 171
39. R. Chiron, Y.Y. Grumbach, N.V. Quynh, V. Verriere, and V. Urbach Lipoxin A(4) and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy J Cyst Fibros 7 2008 463 468